RI
LENZ icon

Rinkey Investments’s LENZ Therapeutics LENZ Stock Holding History

Rinkey Investments’s Portfolio LENZ Stock Details LENZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-15,186
Closed -$139K – 137
2026
Q1 		$139K Hold
15,186
– – 0.04% 124
2025
Q4 		$243K Hold
15,186
– – 0.06% 114
2025
Q3 		$707K Hold
15,186
– – 0.19% 60
2025
Q2 		$445K Hold
15,186
– – 0.13% 65
2025
Q1 		$390K Hold
15,186
– – 0.12% 63
2024
Q4 		$438K Hold
15,186
– – 0.14% 60
2024
Q3 		$361K Buy
+15,186
New +$337K 0.12% 62

Other funds holding LENZ

RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
AWG
Alpha Wave Global New York $6.24B AUM 59.73% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
VVM
Versant Venture Management San Francisco, California $163M AUM 240.43% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Squarepoint
Squarepoint New York $90.5B AUM 33.95% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
7IH
72 Investment Holdings Stamford, Connecticut $50M AUM 647.58% 1-Year Est. Return

Rinkey Investments's LENZ Position: Q2 2026 in Review

Rinkey Investments sold out of LENZ Therapeutics (LENZ) in Q2 2026, closing a stake of 15,186 shares — an estimated $139K sold.

Rinkey Investments first reported a position in LENZ in Q3 2024 and held it in 7 quarters. The position peaked at $707K in Q3 2025. 145 funds tracked by Wall St. Rank hold LENZ as of Q2 2026.

  • Rinkey Investments reported no remaining LENZ Therapeutics position as of Q2 2026 after selling out during the quarter.
  • Rinkey Investments sold 15,186 LENZ Therapeutics shares in Q2 2026, an estimated $139K.
  • Rinkey Investments first reported a position in LENZ Therapeutics in Q3 2024 and held it in 7 quarters.
  • Rinkey Investments's LENZ Therapeutics position peaked at $707K in Q3 2025.
  • 145 funds tracked by Wall St. Rank held LENZ Therapeutics as of Q2 2026.

Based on Rinkey Investments's 13F filing for Q2 2026, filed 20 Jul 2026.